CME and CFTC Clash Over On-Chain Perpetual Futures

The Commodity Futures Trading Commission's recent decision to allow the listing of crypto perpetual futures has ignited a heated battle with the CME Group, the largest derivatives exchange operator in the US. The CME has filed a lawsuit against the CFTC, arguing that the regulator is mislabeling these products and misapplying the law. According to the CME, futures contracts require an expiration date, whereas perpetual futures, also known as perps, are designed for traders to take a position on an asset's price without any deadlines. The CME claims that the CFTC's sudden approval of perps did not consider the potential consequences and could harm its long-dated futures products. The dispute has significant implications for the rapidly growing market, with non-US perps volume reportedly reaching $60 trillion in volume last year. The CFTC's decision to allow perps has been met with frustration from some, who argue that the regulator is not properly enforcing its policies. The CME's lawsuit argues that the CFTC is not prepared to enforce its emerging perps policy, including blocking non-US traders from trading on CFTC-regulated platforms. The CFTC has declined to comment on the matter, while the CME's chairman, Terry Duffy, has stated that the definition of a swap is clear and that the CFTC is not following protocol. The case is ongoing, with both sides awaiting federal court action that could have a significant influence on the US approach to the market. The CME's stance on perps has been viewed by some as an attempt to maintain its dominance in the market and stifle competition. The future of CFTC-driven perps remains uncertain as the CME prepares its case, which includes claims that the agency rubber-stamped the Kalshi application without proper review. The regulatory and tax regimes for swaps and futures are different, and the CME may have the upper hand in this legal dispute. The CFTC's policy statement has opened up the US market for perps, but the lack of a formal rulemaking process has raised concerns about the regulator's approach. The case has significant implications for the market and will be closely watched by industry participants and regulators alike.